Rantum Capital has acquired Tontarra Medizintechnik GmbH (“Tontarra”), a leading German developer and manufacturer of surgical instruments headquartered in Wurmlingen.
Tontarra specializes in the development, manufacturing and distribution of high-precision, premium surgical instruments and endoscopy products for open and minimally invasive surgery. The company offers a comprehensive portfolio of precision instruments used across a broad range of surgical procedures. In addition to its proprietary branded business with patent-protected developments, Tontarra operates as a contract developer and manufacturer for internationally leading MedTech OEMs, covering the entire value chain from development and precision manufacturing through to regulatory approval.
The transaction will support Tontarra’s next phase of development through targeted investments in innovation and the further development of products and markets.
CODEX Partners prepared the commercial due diligence of Tontarra for Rantum Capital.
CODEX Partners advises clients on commercial due diligence, vendor due diligence, strategy development and transformation, as well as on developing industry platforms. Our clients benefit from our experience of more than 850 projects.